Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea



Rating:

Share or cite this content

Citations should be made in the following way:
A. Bikov (Manchester, United Kingdom), S. Frent (Timisoara, Romania), M. Meszaros (Budapest, Hungary), L. Kunos (Budapest, Hungary), A. Mathioudakis (Manchester, United Kingdom), A. Negru (Timisoara, Romania), S. Mihaicuta (Timisoara, Romania). Triglyceride-glucose index in non-diabetic, non-obese patients with obstructive sleep apnoea. 370

Member's Comments

No comment yet.

Related content which might interest you: Differences in polysomnographic (PSG) parameters between obese and non-obese patients with obstructive sleep apnea (OSA) Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea Year: 2019 Impact of obstructive sleep apnoea on insulin resistance in nonobese and obese children Source: Eur Respir J 2016; 47: 1152-1161 Year: 2016 In vitro genioglossus function is different in obese and non-obese patients with obstructive sleep apnea Source: Eur Respir J 2001; 18: Suppl. 33, 332s Year: 2001 Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004 Chronic hypercapnia in morbidly obese patients with obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005 Body composition in obese males with obstructive sleep apnea (OSA) Source: Eur Respir J 2004; 24: Suppl. 48, 572s Year: 2004 Risk of obstructive sleep apnea and impaired glucose metabolism in non-diabetic subjects Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019 Prevalence of non cardiovascular disorders in patients with obstructive sleep apnoea and in ”healthy“ snorers Source: Eur Respir J 2003; 22: Suppl. 45, 92s Year: 2003 Clinical predictors of obesity hypoventilation syndrome in morbidly obese subjects with obstructive sleep apnoea Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I Year: 2015 Gender difference on polysomnographic parameters of severely obese patients with obstructive sleep apnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 331s Year: 2007 Daytime ventilatory instability in obese patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001 The upper airway and obstructive sleep apnea in morbidly obese women Source: Eur Respir J 2004; 24: Suppl. 48, 119s Year: 2004 Hyperuricaemia in males with obstructive sleep apnoea (OSA) Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001 Degree of sleepiness and cardiac alterations in non-hypertensive obstructive sleep apnea (OSA) patients Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Relationship between upper airway and obstructive sleep apnea-hypopnea syndrome in morbidly obese women Source: Eur Respir J 2006; 28: Suppl. 50, 199s Year: 2006 Obstructive sleep apnea in normal weight patients: characteristics and comparison with overweight and obese patients Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019 Hyperuricaemia in females with obstructive sleep apnoea (OSA) Source: Eur Respir J 2003; 22: Suppl. 45, 91s Year: 2003 The association of obstructive sleep apnea with insulin resistance in obese Egyptians Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019 Impact of gender on the relationship between obstructive sleep apnoea and hypertension in an otherwise healthy middle-aged sleep clinic cohort Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008 Adiponectin is not a cardiovascular risk factor in otherwise healthy subjects with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009